1-230843669-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032800.3(C1orf198):c.612G>T(p.Glu204Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,614,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032800.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1orf198 | NM_032800.3 | c.612G>T | p.Glu204Asp | missense_variant | 3/4 | ENST00000366663.10 | NP_116189.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1orf198 | ENST00000366663.10 | c.612G>T | p.Glu204Asp | missense_variant | 3/4 | 1 | NM_032800.3 | ENSP00000355623 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 251044Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135718
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461812Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727212
GnomAD4 genome AF: 0.000341 AC: 52AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 28, 2021 | The c.612G>T (p.E204D) alteration is located in exon 3 (coding exon 3) of the C1orf198 gene. This alteration results from a G to T substitution at nucleotide position 612, causing the glutamic acid (E) at amino acid position 204 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at